All Stories

  1. The lipid profile is altered in Alexander disease
  2. Vimentin remodeling in response to oxidants and electrophiles is modulated by pH
  3. Oxidants modify GFAP and Alexander disease mutants in diverse ways
  4. Posttranslational Regulation of Mammalian Sulfur Amino Acid Metabolism
  5. Lysosomal function, resistance to stress and repair are compromised by expression of the Alexander disease GFAP R239C mutant
  6. Type III intermediate filaments in redox interplay: key role of the conserved cysteine residue
  7. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
  8. Vimentin single cysteine residue acts as a tunable sensor for network organization and as a key for actin remodeling in response to oxidants and electrophiles
  9. Amino Acid Metabolism and Disease
  10. Appraising the Role of Astrocytes as Suppliers of Neuronal Glutathione Precursors
  11. Alexander disease: the road ahead
  12. Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia
  13. Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress
  14. Vimentin Tail Segments Are Differentially Exposed at Distinct Cellular Locations and in Response to Stress
  15. Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia
  16. Amoxicillin Haptenation of α-Enolase is Modulated by Active Site Occupancy and Acetylation
  17. Polar Interactions at the Dimer–Dimer Interface of Methionine Adenosyltransferase MAT I Control Tetramerization
  18. Molecular Insight into the Regulation of Vimentin by Cysteine Modifications and Zinc Binding
  19. Immunolocalization studies of vimentin and ACE2 on the surface of cells exposed to SARS-CoV-2 Spike proteins
  20. Oxidative and Electrophilic Stress Aggravate GFAP Dysfunction in Alexander Disease
  21. Type III intermediate filaments as targets and effectors of electrophiles and oxidants
  22. Amoxicillin Inactivation by Thiol-Catalyzed Cyclization Reduces Protein Haptenation and Antibacterial Potency
  23. Protein-protein interactions involving enzymes of the mammalian methionine and homocysteine metabolism
  24. Vimentin filaments interact with the actin cortex in mitosis allowing normal cell division
  25. Integrated approaches to unravel the impact of protein lipoxidation on macromolecular interactions
  26. Betaine‐homocysteine S ‐methyltransferase deficiency causes increased susceptibility to noise‐induced hearing loss associated with plasma hyperhomocysteinemia
  27. Vimentin disruption by lipoxidation and electrophiles: Role of the cysteine residue and filament dynamics
  28. The relationship between what we eat and hearing
  29. Identification of hepatic protein-protein interaction targets for betaine homocysteine S-methyltransferase
  30. Asthma and allergic rhinitis associate with the rs2229542 variant that induces a p.Lys90Glu mutation and compromises AKR1B1 protein levels
  31. Mammalian Sulfur Amino Acid Metabolism: A Nexus Between Redox Regulation, Nutrition, Epigenetics, and Detoxification
  32. Alterations in Nucleocytoplasmic Localization of the Methionine Cycle Induced by Oxidative Stress During Liver Disease
  33. PDRG1 at the interface between intermediary metabolism and oncogenesis
  34. Cochlear Homocysteine Metabolism at the Crossroad of Nutrition and Sensorineural Hearing Loss
  35. Betaine homocysteine S-methyltransferase emerges as a new player of the nuclear methionine cycle
  36. Correction: The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases
  37. Long-Term Dietary Folate Deficiency Accelerates Progressive Hearing Loss on CBA/Ca Mice
  38. The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases
  39. Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase
  40. Long-term omega-3 fatty acid supplementation prevents expression changes in cochlear homocysteine metabolism and ameliorates progressive hearing loss in C57BL/6J mice
  41. Regulación redox del ciclo de la metionina
  42. The deficit in folic acid accelerates hearing loss
  43. Acute Liver Injury Induces Nucleocytoplasmic Redistribution of Hepatic Methionine Metabolism Enzymes
  44. Modulation of GSTP1-1 Oligomerization by Electrophilic Inflammatory Mediators and Reactive Drugs
  45. Redox stress regulates production of the main cellular methyl donor S-adenosylmethionine
  46. Structural Studies of Betaine Homocysteine Methyl Transferase (BHMT) and a Dimeric Mutant by Conventional and 2DCOS Moving Lapse IR Spectroscopy
  47. NADP+ Binding to the Regulatory Subunit of Methionine Adenosyltransferase II Increases Intersubunit Binding Affinity in the Hetero-Trimer
  48. Methionine Adenosyltransferase (S-Adenosylmethionine Synthetase)
  49. Refolding and characterization of methionine adenosyltransferase from Euglena gracilis
  50. Structural basis for the stability of a thermophilic methionine adenosyltransferase against guanidinium chloride
  51. Las otras utilidades de los aminoácidos
  52. Cyclopentenone Prostaglandins with Dienone Structure Promote Cross-Linking of the Chemoresistance-Inducing Enzyme Glutathione Transferase P1-1
  53. Subunit association as the stabilizing determinant for archaeal methionine adenosyltransferases
  54. Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution
  55. Structure-function relationships in methionine adenosyltransferases
  56. Early effects of copper accumulation on methionine metabolism
  57. Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism?
  58. Rat liver betaine–homocysteine S-methyltransferase equilibrium unfolding: insights into intermediate structure through tryptophan substitutions
  59. Methionine Adenosyltransferase α-Helix Structure Unfolds at Lower Temperatures than β-Sheet: A 2D-IR Study
  60. BHMT from rat liver
  61. Crystal Structure of Rat Liver Betaine Homocysteine S-Methyltransferase Reveals New Oligomerization Features and Conformational Changes Upon Substrate Binding
  62. Methionine Adenosyltransferase as a Useful Molecular Systematics Tool Revealed by Phylogenetic and Structural Analyses
  63. Cu2+binding triggers αBoPrP assembly into insoluble laminar polymers
  64. Crystal Structures of Methionine Adenosyltransferase Complexed with Substrates and Products Reveal the Methionine-ATP Recognition and Give Insights into the Catalytic Mechanism
  65. Methionine Adenosyltransferase complexed with ADP and a L-methionine analogous
  66. Methionine adenosyltransferase complexed with both substrates ATP and methionine
  67. Methionine Adenosyltransferase complexed with a L-methionine analogous
  68. Active-site-mutagenesis study of rat liver betaine-homocysteine S-methyltransferase
  69. Role of an Intrasubunit Disulfide in the Association State of the Cytosolic Homo-oligomer Methionine Adenosyltransferase
  70. Leishmania donovanimethionine adenosyltransferase
  71. Crystallization and preliminary X-ray study of recombinant betaine–homocysteineS-methyltransferase from rat liver
  72. Prion Protein Interaction with Glycosaminoglycan Occurs with the Formation of Oligomeric Complexes Stabilized by Cu(II) Bridges
  73. Equilibrium unfolding studies of the rat liver methionine adenosyltransferase III, a dimeric enzyme with intersubunit active sites
  74. Equilibrium unfolding studies of the rat liver methionine adenosyltransferase III, a dimeric enzyme with intersubunit active sites
  75. METHIONINE ADENOSYLTRANSFERASE COMPLEXED WITH A L-METHIONINE ANALOGOUS
  76. The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site 1 1Edited by R. Huber
  77. Refolding and Characterization of Rat Liver Methionine Adenosyltransferase from Escherichia coli Inclusion Bodies
  78. Assignment of a single disulfide bridge in rat liver methionine adenosyltransferase
  79. Characterization of Rat Liver-specific Methionine Adenosyltransferase Gene Promoter: ROLE OF DISTAL UPSTREAM cis-ACTING ELEMENTS IN THE REGULATION OF THE TRANSCRIPTIONAL ACTIVITY
  80. Recombinant rat liver S-adenosyl-l-methionine synthetase tetramers and dimers are in equilibrium
  81. Glucocorticoid Regulation of Hepatic S-Adenosylmethionine Synthetase Gene Expression
  82. Glucocorticoid Regulation of HepaticS-Adenosylmethionine Synthetase Gene Expression1
  83. S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications
  84. Role of thioltransferases on the modulation of rat liver S-adenosylmethionine synthetase activity by glutathione
  85. Increased sensitivity to oxidative injury in chinese hamster ovary cells stably transfected with rat liver S-adenosylmethionine synthetase cDNA
  86. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development
  87. Differential expression pattern ofS-adenosylmethionine synthetase isoenzymes during rat liver development
  88. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis
  89. Study of the rat liverS-adenosylmethionine synthetase active site with 8-azido ATP
  90. Expression of rat liverS-adenosylmethionine synthetase inEscherichia coliresults in two active oligomeric forms
  91. S-Adenosyl-L-Methionine Synthetase and Methionine Metabolism Deficiencies in Cirrhosis
  92. S –Adenosylmethionine Treatment Prevents Carbon Tetrachloride—Induced S –Adenosylmethionine Synthetase Inactivation and Attenuates Liver Injury
  93. How is rat liver S -adenosylmethionine synthetase regulated?
  94. Impairment of Methionine Metabolism in Liver Disease
  95. Analysis of the 5′ non-coding region of rat liver S -adenosylmethionine synthetase mRNA and comparison of the M r deduced from the cDNA sequence and the purified enzyme
  96. Inhibition of glutathione synthesis in the liver leads toS-adenosyl-L-methionine synthetase reduction
  97. Fourier transform infrared studies of active-site-methylated rhodopsin. Implications for chromophore-protein interaction, transducin activation, and the reaction pathway
  98. Reduced S-adenosylmethionine synthetase mRNA levels in liver biopsies from cirrhotic subjects
  99. Inactivation and dissociation ofs-adenosylmethionine synthetase by modification of sulfhydryl groups and its possile occurrence in cirrhosis
  100. Mechanisms and Consequences of the Impaired Trans-Sulphuration Pathway in Liver Disease
  101. Structural basis of protein kinase C activation by tumor promoters.
  102. Calcium-dependent binding between calmodulin and lysozyme
  103. Purification of phospholipid methyltransferase from rat liver microsomal fraction
  104. Regulation of Phospholipid Methylation by Reversible Phosphorylation
  105. Modulation by the ratio S-adenosylmethionineS-adenosylhomocysteine of cyclic AMP-dependent phosphorylation of the 50 kDa protein of rat liver phospholipid methyltransferase
  106. How many phospholipid methyltransferases are there in mammalian cells?
  107. Purification and photoaffinity labelling of lipid methyltransferase from rat liver
  108. Activation of partially purified rat liver lipid methyltransferase by phosphorylation